Opioid-induced respiratory depression increases hospital costs and length of stay in patients recovering on the general care floor.

ABSTRACT:

Background

Opioid-induced respiratory depression is common on the general care floor. However, the clinical and economic burden of respiratory depression is not well-described. The PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) trial created a prediction tool to identify patients at risk of respiratory depression. The purpose of this retrospective sub-analysis was to examine healthcare utilization and hospital cost associated with respiratory depression.

Methods

One thousand three hundred thirty-five patients (N = 769 United States patients) enrolled in the PRODIGY trial received parenteral opioids and underwent continuous capnography and pulse oximetry monitoring. Cost data was retrospectively collected for 420 United Stat

SUBMITTER: Khanna AK 

PROVIDER: S-EPMC7980593 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature